Relative cerebral blood volume is a potential predictive imaging biomarker of bevacizumab efficacy in recurrent glioblastoma

BACKGROUND: To analyze the relevance of dynamic susceptibility-weighted contrast-enhanced MRI (DSC-MRI) derived relative cerebral blood volume (rCBV) analysis for predicting response to bevacizumab (BEV) in patients with recurrent glioblastoma (rGB). METHODS: A total of 127 patients diagnosed with r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Kickingereder, Philipp, Wiestler, Benedikt, Burth, Sina, Wick, Antje, Nowosielski, Martha, Heiland, Sabine, Schlemmer, Heinz-Peter, Wick, Wolfgang, Bendszus, Martin, Radbruch, Alexander
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Neuroimaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490872/
https://ncbi.nlm.nih.gov/pubmed/25754089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados